Gapicomine
From Self-sufficiency
File:Gapicomine.png | |
Systematic (IUPAC) name | |
---|---|
1-Pyridin-4-yl-N-(pyridin-4-ylmethyl)methanamine | |
Clinical data | |
Routes of administration | oral (tablet) |
Legal status | |
Legal status |
|
Identifiers | |
CAS Number | 1539-39-5 |
ATC code | none |
PubChem | CID 68955 |
Chemical data | |
Formula | C12H13N3 |
Molar mass | 199.25 g/mol[[Script error: No such module "String".]] |
Gapicomine (INN) is a coronary vasodilator. It has been withdrawn from the market in the countries it was used in.[1]
Also, gapicomine is a major component in the drug bicordin.[2]
History
Gapicomine was discovered in 1970 by Polish chemist Stanisław Biniecki. It was first published about in an article of The Polish Journal of Medicine and Pharmacy describing the derivative drug bicordin in 1974.[3]
References
Cite error: Invalid <references>
tag;
parameter "group" is allowed only.
<references />
, or <references group="..." />
30px | This drug article relating to the cardiovascular system is a stub. You can help ssf by expanding it. |
- ↑ "Gapicomine Monograph, The Index Nominum". Retrieved 2008-03-31.
- ↑ "Bicordin, PubChem". Retrieved 2008-03-31.
- ↑ Samochowiec L, Wójcicki J, Gregorczyk K, Szmatloch E. (1974). "Bicordin--a new drug in the treatment of coronary heart disease". Mater Med Pol. 6 (4): 298–300. PMID 4453155.
Categories:
- Pages with script errors
- Pages with broken file links
- Infobox drug tracked parameters
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs not assigned an ATC code
- Articles containing unverified chemical infoboxes
- 2Fix
- Pyridines
- Vasodilators
- Cardiovascular system drug stubs
- CS1 maint: Multiple names: authors list